Dublin, Nov. 30, 2017 -- The "Heated Tobacco: Product Launches, Regulations and Future Outlook" report has been added to Research and Markets' offering.
Heat-not-burn could compete with e-cigarettes for consumer attention, but it may also attract new users. What progress has the recent spate of launches made, what regulations are affecting the industry and what might the future hold? In this detailed, 72-page report, an overview of the market, the background of the market and a look at European regulations is provided.
At present, the main HnB products are iQOS and Glo, the latter coming from British American Tobacco (BAT). The main hybrid devices are iFuse, from BAT, and Ploom Tech, from Japan Tobacco (JTI). The category is not new, however, but it is only recently that it has come to the fore.
Heat-not-burn devices differ from e-cigs in one key area, and that is the heating of actual tobacco. However, it is worth noting that many in the e-cigarette sector have concerns that rules of these products will have an impact on e-cigarettes, and that the two categories will be treated the same way for regulatory and tax purposes.
Key Topics Covered:
Part One: Current Market Overview
Part Two: Market Background (November 2016)
Part Three: Regulation In Europe
Appendix: Science
Companies Mentioned
- British American Tobacco (BAT)
- Glo
- iQOS
For more information about this report visit https://www.researchandmarkets.com/research/pk4xc7/heated_tobacco
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Tobacco


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anta Sports Expands Global Footprint With Strategic Puma Stake
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



